Atlas Trials

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

Clinical trial NCT02051387 · COMPLETED

Trial details

NCT number
NCT02051387
Sponsor
Central Institute of Mental Health, Mannheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-01-01
Primary completion
2017-08-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.